A 60-year-old female with underlying emphysema and left ventricular assist device (LVAD) HeartMate 3 presented with progressive hemoptysis, dyspnea, and right chest pain. Baseline hemoglobin was 11.1 g/dL and INR 2.9. A chest computed tomography showed enlargement of a right lung bulla with internal hemorrhage, measuring 105.6 mm in its widest diameter, and fluid-air level in its more cephalic portion (Fig. 1). Anticoagulation was held and cardiothoracic surgery consulted. The 2nd day, the LVAD had low-flow alarms, her hemoglobin decreased to 6.1 g/dL and she developed hypovolemic shock and hypoxic respiratory failure requiring intubation, blood transfusion, and inotrope/vasopressor therapy. A chest tube was placed for hemothorax, draining 2.7 L of blood. Angiography showed no active contrast extravasation but the hemothorax persisted through the next day. A second angiography was performed, during which a Montefiore pigtail catheter was advanced over a 0.035 in wire into the right pulmonary artery and diagnostic angiography was performed. Although no extravasation was evidenced, it was empirically decided to plug the right lower lobe artery to halt further hemothorax, for which a 18 mm Amplatzer Vascular Plug II was deemed to provide appropriate occlusion. The catheter and sheath were was exchanged for a 7 French by 100 cm Ansel sheath, which was advanced into the right lower lobe pulmonary artery. An 18 mm Amplatzer Vascular Plug II was advanced through the sheath and successfully deployed in the right lower lobe pulmonary artery (Fig. 2), and the hemorrhagic output decreased. She underwent surgical washout with removal of 1 L of clot. Her admission also complicated with an acute ischemic stroke and ventilator-associated pneumonia and was discharged on hospital day 32 without residual neurological deficits.
Bleeding and thrombosis are seen less frequently with centrifugal-flow pumps such as HeartMate 31; nonetheless, bleeding complications continue to pose significant morbidity and mortality for patients with LVADs. This case highlights the importance of coordinated multidisciplinary management and the ingenious use of transcatheter interventions, such as pulmonary arterial occlusion with Amplatzer devices, to achieve bleeding-source control in patients with LVADs.